Real-time enrollment status for this muscular dystrophy, facioscapulohumeral clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:45 AM UTC
| NCT Number | NCT06721299 |
| Recruiting Status | Recruiting |
| Condition | Muscular Dystrophy, Facioscapulohumeral |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Jeffrey Statland |
| Last Updated on CT.gov | February 25, 2026 (Feb 25, 2026) |
As of July 13, 2026: Clinical trial NCT06721299 is currently recruiting participants. This clinical trial study for muscular dystrophy, facioscapulohumeral is actively seeking new participants at 3 locations across the United States. The study is sponsored by Jeffrey Statland. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06721299 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06721299 was last updated Feb 25, 2026 (February 25, 2026). HelloStudys verifies this status automatically.